Clues to Reshaping Anti‐α‐Synuclein Immunotherapy in Early Parkinson's Disease Patients
Sign Up to like & getrecommendations! Published in 2022 at "Movement Disorders"
DOI: 10.1002/mds.29294
Abstract: Alpha-synuclein (α-syn) aggregates are the hallmark pathological inclusions of Parkinson’s disease (PD). Even though its mechanisms of action are still unclear, multiple pathways of cellular dysfunction in models of α-syn toxicity have been described, and… read more here.
Keywords: immunotherapy; syn aggregates; parkinson disease; syn ... See more keywords